scispace - formally typeset
G

Guanmin Jiang

Researcher at Sun Yat-sen University

Publications -  45
Citations -  3995

Guanmin Jiang is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 20, co-authored 32 publications receiving 2222 citations. Previous affiliations of Guanmin Jiang include Central South University.

Papers
More filters
Journal ArticleDOI

Prolonged presence of SARS-CoV-2 viral RNA in faecal samples.

TL;DR: Real-time RT-PCR results of all respiratory and faecal samples from patients with coronavirus disease 2019 (COVID-19) at the Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China, throughout the course of their illness and obligated quarantine period show associations that should be interpreted with caution because of the possibility of confounding.
Posted ContentDOI

Evidence for gastrointestinal infection of SARS-CoV-2

TL;DR: Evidence is provided for gastrointestinal infection of SARS-CoV-2, highlighting its potential fecal-oral transmission route and positive immunofluorescent staining of viral host receptor ACE2 and viral nucleocapsid protein in a case of Sars-Co V-2 infection.
Journal ArticleDOI

TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype

TL;DR: It is found that TGF-β induces a M2-like phenotype characterized by up-regulation of the anti-inflammatory cytokine IL-10, and down- regulation of the pro- inflammatory cytokines TNF-α and IL-12, which suggests a potential therapeutic target for antitumor immunity.
Journal ArticleDOI

m 6 A-induced lncRNA RP11 triggers the dissemination of colorectal cancer cells via upregulation of Zeb1

TL;DR: m6A-induced lncRNA RP11 can trigger the dissemination of CRC cells via post-translational upregulation of Zeb1, and clinical analysis showed that m6A can regulate the expression of RP11.
Journal ArticleDOI

The relationship between autophagy and the immune system and its applications for tumor immunotherapy

TL;DR: Increasing studies have proven the optimal use of either ATG inducers or inhibitors can restrain tumor growth and progression by enhancing anti-tumor immune responses and overcoming the anti- Tournaisian immune resistance in combination with several immunotherapeutic strategies, indicating that induction or inhibition of autophagy might show a prospective therapeutic strategy when combined with immunotherapy.